GNFT logo

Genfit SA (GNFT) Company Overview

Profile

Full Name:

Genfit S.A.

Sector:

Healthcare

Industry:

Biotechnology

Country:

France

IPO:

March 27, 2019

Indexes:

Not included

Website:

http://www.genfit.com

Description:

Genfit SA is a biopharmaceutical company focused on developing innovative therapies for metabolic and liver diseases. They specialize in research and clinical trials to create treatments that improve patient outcomes, particularly in conditions like non-alcoholic steatohepatitis (NASH) and other liver disorders.

Key Details

Price

$3.65

Market Cap

$182.16 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$30.92 M(+45.20% YoY)

Annual EPS

-$0.63(-24.04% YoY)

PE Ratio

-

Annual ROE

-35.45%

Annual Debt To Equity

0.95

Beta

0.26

Events Calendar

Earnings

Next earnings date:

Apr 24, 2025

Recent quarterly earnings:

Sep 19, 2024

Recent annual earnings:

Apr 4, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 7, 25 HC Wainwright & Co.
Buy
Oct 11, 24 HC Wainwright & Co.
Buy
Sep 20, 24 HC Wainwright & Co.
Buy
Jul 29, 24 HC Wainwright & Co.
Buy
Jun 11, 24 HC Wainwright & Co.
Buy
Jun 6, 24 HC Wainwright & Co.
Buy
May 15, 24 HC Wainwright & Co.
Buy
Apr 5, 24 HC Wainwright & Co.
Buy
Dec 8, 23 HC Wainwright & Co.
Buy
Sep 21, 23 HC Wainwright & Co.
Buy

Screeners with GNFT included

Growing Shares Outstanding
Stocks below SMA 200
Healthcare sector
All stocks
NASDAQ Listed Companies
Biggest stock gainers today
Biotechnology industry
Small cap stocks
Stocks with low beta
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$3.65
GNFT price is $3.65

Price All-time High

$25.65
GNFT price is currently -85.77% below its historical high of $25.65

Price Analysts Target

-
GNFT price consensus analysts' forecast is unknown

Price Most Recent Change

+7.67%
GNFT price was up +7.67% on Mar 7, 2025

Price YTD Change

-1.75%
GNFT price is down -1.75% since January 1st

Price 3-Year Change

+16.24%
GNFT price is up +16.24% over the past 3 years

Market cap

Market Cap

$182.16 M
GNFT market capitalization is $182.16 million

Market Cap 3-Year Change

+16.45%
GNFT market capitalization is up +16.45% over the past 3 years

Market Cap All-time High

$996.03 M
GNFT market capitalization is currently -81.71% below its historical high of $996.03 million

Market Cap Sector Rank

54.16%
GNFT market capitalization is higher than 54.16% of companies in Healthcare sector

Technical

Beta

0.26
GNFT beta is 0.26

200-day SMA

$4.40
GNFT price is currently -16.97% below its 200-day simple moving average

14-day RSI

48.28
GNFT 14-day relative strength index is 48.28

30-day Relative Volume

1.79
GNFT 30-day relative volume is 1.79

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$30.92 M
GNFT annual revenue is $30.92 million

Annual Revenue Analysts Estimate

$84.74 M
GNFT annual revenue is currently -63.50% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+45.2%
GNFT annual revenue is up +45.2% year-on-year

Annual Revenue Sector Rank

42.3%
GNFT annual revenue is higher than 42.3% of companies in Healthcare sector

Profit

Annual Gross Profit

$30.56 M
GNFT annual gross profit is $30.56 million

Annual Gross Margin

98.81%
GNFT annual gross profit margin is 98.81%

Annual Operating Profit

-$29.41 M
GNFT annual operating income is -$29.41 million

Annual Operating Margin

-95.10%
GNFT annual operating profit margin is -95.10%

Annual Net Income

-$31.28 M
GNFT annual net profit is -$31.28 million

Annual Net Margin

-101.15%
GNFT annual net profit margin is -101.15%

EPS

Annual EPS

-$0.63
GNFT annual earnings per share is -$0.63

Annual EPS Analysts Estimate

$0.58
GNFT annual earnings per share is currently -208.26% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-24.04%
GNFT annual earnings per share is down -24.04% year-on-year

Annual EPS Sector Rank

65.73%
GNFT annual earnings per share is higher than 65.73% of companies in Healthcare sector

ROA & ROE

Annual ROA

-14.78%
GNFT annual return on assets is -14.78%

Annual ROE

-35.45%
GNFT annual return on equity is -35.45%

EBIT & EBITDA

Annual EBIT

-$25.86 M
GNFT annual earnings before interest & taxes is -$25.86 million

Annual EBITDA

-$24.07 M
GNFT annual EBITDA is -$24.07 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
GNFT price to earnings ratio value is unknown

PE Ratio Sector Rank

-
GNFT price to earnings ratio is unknown

PB Ratio

PB Ratio

1.75
GNFT price to book ratio is 1.75

PB Ratio Sector Rank

56.18%
GNFT price to book ratio is higher than 56.18% of companies in Healthcare sector

PS Ratio

PS Ratio

-
GNFT price to sales ratio value is unknown

PS Ratio Sector Rank

-
GNFT price to sales ratio is unknown

Enterprise value

Enterprise Value

$188.76 M
GNFT enterprise value is $188.76 million

Enterprise Value Sector Rank

56.02%
GNFT enterprise value is higher than 56.02% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
GNFT EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
GNFT EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.94
GNFT annual current ratio is 2.94

Annual Quick Ratio

2.94
GNFT annual quick ratio is 2.94

Leverage

Annual Debt To Equity

0.95
GNFT annual debt to equity ratio is 0.95

Annual Interest Coverage Ratio

-5.17
GNFT annual interest coverage ratio is -5.17

Risk & Stability

Piotroski F-Score

-
GNFT piotroski f-score value is unknown

Altman Z-Score

-1.98
GNFT altman z-score is -1.98

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$192.20 M
GNFT annual total assets is $192.20 million

Annual Non Current Assets

$67.16 M
GNFT annual long term assets is $67.16 million

Annual Current Assets

$125.04 M
GNFT annual total current assets is $125.04 million

Annual Cash & Cash Equivalents

$85.99 M
GNFT annual cash & cash equivalents is $85.99 million

Equity

Annual Book Value

$75.11 M
GNFT annual book value is $75.11 million

Annual Working Capital

$82.50 M
GNFT annual working capital is $82.50 million

Liabilities

Annual Total Liabilities

$117.09 M
GNFT annual total liabilities is $117.09 million

Annual Total Long Term Liabilities

$74.55 M
GNFT annual total long term liabilities is $74.55 million

Annual Current Liabilities

$42.54 M
GNFT annual total current liabilities is $42.54 million

Annual Accounts Payable

$11.55 M
GNFT annual accounts payable is $11.55 million

Debt

Annual Total Debt

$77.58 M
GNFT annual total debt is $77.58 million

Annual Total Debt 1-Year Change

-3.9%
GNFT annual total debt is down -3.9% year-on-year

Annual Long Term Debt

$68.81 M
GNFT annual long term debt is $68.81 million

Annual Short Term Debt

$8.76 M
GNFT annual short term debt is $8.76 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$60.33 M
GNFT annual total expenses is $60.33 million

Annual Operating Expenses

$59.96 M
GNFT annual total operating expenses is $59.96 million

Annual Cost Of Goods Sold

$369.20 K
GNFT annual cost of goods sold is $369.20 thousand

Annual SGA

$8.71 M
GNFT annual SGA is $8.71 million

Annual D&A

$1.79 M
GNFT annual depreciation & amortization is $1.79 million

Annual Interest Expense

$5.01 M
GNFT annual interest expense is $5.01 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$60.01 M
GNFT annual cash flow from operations is -$60.01 million

Annual CFO 1-Year Change

+21.66%
GNFT annual cash flow from operations is up +21.66% year-on-year

Annual CFI

$2.42 M
GNFT annual cash flow from investing activities is $2.42 million

Annual CFI 1-Year Change

+104.96%
GNFT annual cash flow from investing activities is up +104.96% year-on-year

Annual CFF

-$5.52 M
GNFT annual cash flow from financing activities is -$5.52 million

Annual CFF 1-Year Change

-38.23%
GNFT annual cash flow from financing activities is down -38.23% year-on-year

Free CashFlow

Annual FCF

-$62.70 M
GNFT annual free cash flow is -$62.70 million

Annual FCF 1-Year Change

+18.15%
GNFT annual free cash flow is up +18.15% year-on-year

CAPEX

Annual CAPEX

$2.69 M
GNFT annual capital expenditures is $2.69 million

Annual CAPEX 1-Year Change

-
GNFT annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

CGC logo
Canopy Growth (CGC)
OCGN logo
Ocugen (OCGN)
BWAY logo
BrainsWay (BWAY)
TLSA logo
Tiziana Life Sciences Ltd (TLSA)
PFMT logo
Performant Financial (PFMT)
Atlantic International (ATLN)
CATX logo
Perspective Therapeutics (CATX)
MOLN logo
Molecular Partners AG (MOLN)
INMB logo
INmune Bio (INMB)

FAQ

  • What is the ticker symbol for Genfit SA?
  • Does Genfit SA pay dividends?
  • What sector is Genfit SA in?
  • What industry is Genfit SA in?
  • What country is Genfit SA based in?
  • When did Genfit SA go public?
  • Is Genfit SA in the S&P 500?
  • Is Genfit SA in the NASDAQ 100?
  • Is Genfit SA in the Dow Jones?
  • When was Genfit SA's last earnings report?
  • When does Genfit SA report earnings?

What is the ticker symbol for Genfit SA?

The ticker symbol for Genfit SA is NASDAQ:GNFT

Does Genfit SA pay dividends?

No, Genfit SA does not pay dividends

What sector is Genfit SA in?

Genfit SA is in the Healthcare sector

What industry is Genfit SA in?

Genfit SA is in the Biotechnology industry

What country is Genfit SA based in?

Genfit SA is headquartered in France

When did Genfit SA go public?

Genfit SA's initial public offering (IPO) was on March 27, 2019

Is Genfit SA in the S&P 500?

No, Genfit SA is not included in the S&P 500 index

Is Genfit SA in the NASDAQ 100?

No, Genfit SA is not included in the NASDAQ 100 index

Is Genfit SA in the Dow Jones?

No, Genfit SA is not included in the Dow Jones index

When was Genfit SA's last earnings report?

Genfit SA's most recent earnings report was on Sep 19, 2024

When does Genfit SA report earnings?

The next expected earnings date for Genfit SA is Apr 24, 2025